Isomorphic Labs prepares to launch trials for AI-designed drugs
By Abigail Beaney
CTO East Coast 2025: Navigating shifting regulatory environment hinges on close alignment
By Ross Law
Jasper shares decline following trial setback from faulty drug batch
By Abigail Beaney
Taiho’s DMD therapy misses the mark in Phase III trial
By Abigail Beaney
Novartis’ Cosentyx shows no benefit in Phase III GCA trial
By Abigail Beaney
PanTher Therapeutics launches second trial for chemotherapy patch
By Abigail Beaney
Study finds UK leads Europe in clinical trial set-up speed
By Abigail Beaney
Organon discontinues endometriosis drug after Phase II flunk
By Abigail Beaney
Judge orders FDA to reinstate clinical trial diversity webpages
By Abigail Beaney
UK Government reveals 10-year plan for NHS
By Ross Law